Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Pregnant Women at High Risk Following C.S.

Trial Profile

Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Pregnant Women at High Risk Following C.S.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Carbetocin (Primary) ; Misoprostol (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2017 Planned End Date changed from 1 Mar 2016 to 1 Dec 2017.
    • 19 Jul 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2017.
    • 28 Dec 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top